rs189277711

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001009944.3(PKD1):​c.6927C>T​(p.Gly2309=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0179 in 1,553,324 control chromosomes in the GnomAD database, including 308 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 24 hom., cov: 33)
Exomes 𝑓: 0.018 ( 284 hom. )

Consequence

PKD1
NM_001009944.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -1.39
Variant links:
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 16-2108021-G-A is Benign according to our data. Variant chr16-2108021-G-A is described in ClinVar as [Benign]. Clinvar id is 256994.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2108021-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-1.39 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0138 (2097/152288) while in subpopulation NFE AF= 0.0195 (1323/68004). AF 95% confidence interval is 0.0186. There are 24 homozygotes in gnomad4. There are 1040 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 2097 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PKD1NM_001009944.3 linkuse as main transcriptc.6927C>T p.Gly2309= synonymous_variant 16/46 ENST00000262304.9 NP_001009944.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PKD1ENST00000262304.9 linkuse as main transcriptc.6927C>T p.Gly2309= synonymous_variant 16/461 NM_001009944.3 ENSP00000262304 P5P98161-1

Frequencies

GnomAD3 genomes
AF:
0.0138
AC:
2097
AN:
152170
Hom.:
24
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00367
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0101
Gnomad ASJ
AF:
0.00634
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.00559
Gnomad FIN
AF:
0.0369
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0195
Gnomad OTH
AF:
0.0110
GnomAD3 exomes
AF:
0.0131
AC:
2000
AN:
152096
Hom.:
39
AF XY:
0.0130
AC XY:
1071
AN XY:
82084
show subpopulations
Gnomad AFR exome
AF:
0.00357
Gnomad AMR exome
AF:
0.00482
Gnomad ASJ exome
AF:
0.00522
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00675
Gnomad FIN exome
AF:
0.0315
Gnomad NFE exome
AF:
0.0197
Gnomad OTH exome
AF:
0.0137
GnomAD4 exome
AF:
0.0184
AC:
25727
AN:
1401036
Hom.:
284
Cov.:
31
AF XY:
0.0180
AC XY:
12434
AN XY:
691940
show subpopulations
Gnomad4 AFR exome
AF:
0.00292
Gnomad4 AMR exome
AF:
0.00584
Gnomad4 ASJ exome
AF:
0.00503
Gnomad4 EAS exome
AF:
0.0000275
Gnomad4 SAS exome
AF:
0.00704
Gnomad4 FIN exome
AF:
0.0331
Gnomad4 NFE exome
AF:
0.0206
Gnomad4 OTH exome
AF:
0.0145
GnomAD4 genome
AF:
0.0138
AC:
2097
AN:
152288
Hom.:
24
Cov.:
33
AF XY:
0.0140
AC XY:
1040
AN XY:
74476
show subpopulations
Gnomad4 AFR
AF:
0.00366
Gnomad4 AMR
AF:
0.0101
Gnomad4 ASJ
AF:
0.00634
Gnomad4 EAS
AF:
0.000386
Gnomad4 SAS
AF:
0.00580
Gnomad4 FIN
AF:
0.0369
Gnomad4 NFE
AF:
0.0195
Gnomad4 OTH
AF:
0.0109
Alfa
AF:
0.0152
Hom.:
9
Bravo
AF:
0.0119
Asia WGS
AF:
0.00289
AC:
10
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsMar 04, 2020- -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxOct 17, 2019This variant is associated with the following publications: (PMID: 11967008, 11857740, 10854095) -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Polycystic kidney disease, adult type Benign:1
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesMar 23, 2020- -
Polycystic kidney disease Benign:1
Benign, no assertion criteria providedclinical testingDepartment of Pathology and Laboratory Medicine, Sinai Health System-The PKD1 p.Gly2309Gly variant was identified in 17 of 732 proband chromosomes (frequency: 0.023) from individuals or families with ADPKD or renal disease, and was not identified in 100 control chromosomes from healthy individuals (Bataille 2011, Garcia-Gonzalez 2007, McCluskey 2002, Rossetti 2012). The above studies determined this variant to be classified as a polymorphism based on either it being a synonymous variant, in silico analysis or interspecies conservation. The p.Gly2309Gly variant was identified in the dbSNP (ID: rs189277711) with unknown clinical significance with a minor allele frequency 0.0082 (41 of 5000 chromosomes in 1000 Genome Project). In the NHLBI Exome Sequencing Project, the variant was identified in 119 of 7256 alleles (frequency: 0.0164) in European Americans and 10 of 3486 African Americans (frequency: 0.00286). The variant was identified in the Exome Aggregation Consortium database (March 14, 2016) in 214 of 15790 alleles, 5 of which are homozygous (frequency: 0.0135) or 6 of 56 of European (Finnish), 138 of 5652 European (Non-Finnish), 8 of 380 Latino, 7 of 1120 African, 54 of 7844 South Asians, 1 of 168 other alleles and was not found in East Asians. The variant was identified in the ADPKD Mutation Database and classified as likely neutral. The c.6927C>T variant occurs outside of the splicing consensus sequence and 4 of 5 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) predict a location change of a cryptic 5’ splice donor site; this is not very predictive of pathogenicity. The p.Gly2309Gly variant is not expected to have clinical significance because it does not result in a change of amino acid and is not located in a known consensus splice site. In addition this variant was identified by our laboratory as co-occurring with pathogenic PKD1 variants in two different families with polycystic kidney disease (PKD1, EXON43, c.11798_11810del, p.Leu3933ArgfsX8 and c.2215C>T, p.Gln739X), increasing the likelihood that this variant does not have clinical significance. In summary, based on the above information, this variant meets our criteria to be classified as benign. -
Autosomal dominant polycystic kidney disease Benign:1
Benign, criteria provided, single submitterresearchMolecular Genetics of Inherited Kidney Disorders Laboratory, Garvan Institute of Medical ResearchJan 01, 2019- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
0.34
DANN
Benign
0.86

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs189277711; hg19: chr16-2158022; COSMIC: COSV99237445; COSMIC: COSV99237445; API